The document discusses treatment options for locally advanced larynx cancer. It notes that 60% of patients present with locally advanced stage III/IV disease where combined modality treatment with chemoradiation is recommended. While chemoradiation provides good local control and survival, it can impact swallowing and voice functions. Ongoing trials aim to optimize organ preservation strategies to minimize these side effects through techniques like IMRT while maintaining oncologic outcomes.